logo

For the Inventor, By the Inventor

Davis, CA, United States of America

Paul A Luciw

This inventor holds 18 USPTO granted patents, plus 1 CIPO patent, primarily in HIV Research. Top assignees: Novartis Vaccines & Diagnostics, Gmbh, Chiron Corporation, University of California. Active years: 1989-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul A Luciw. Retrieved from https://idiyas.com/inventor/paul-a-luciw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 100.0


Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 151(Granted Patents)


Location History:

  • Emeryville, CA (US) (1989 - 1992)
  • Davis, CA (US) (1992 - 2010)

Company Filing History:

goldMedal9 out of 245 
 
Novartis Vaccines & Diagnostics, Gmbh
 patents
silverMedal7 out of 672 
 
Chiron Corporation
 patents
bronzeMedal2 out of 16,082 
 
University of California
 patents

Years Active: 1989-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
HIV Nucleotide Sequences
Recombinant DNA
Polypeptides
Immunoassays
Vaccine Development
Synthetic Polypeptides
Lentivirus Vectors
Antigenic Composition
GAG Polypeptides
Pol DNA
Feline Leukemia Virus
HIV Antibodies
18 patents (USPTO):Explore Patents
1. RE41158 - Human immunodeficiency virus (HIV) nucleotide sequences (2010-03-01),
2. 7527925 - Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such construct (2009-05-05),
3. 7442525 - Method for expressing HIV polypeptides (2008-10-28),
4. 7425428 - Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced thereby (2008-09-16),
5. 7408053 - Recombinant DNA constructs for GAG polypeptides and polypeptides produced thereby (2008-08-05),
6. 7393949 - Human immunodeficiency virus (HIV) nucleotide sequences (2008-07-01),
7. 7285271 - Antigenic composition comprising an HIV gag or env polypeptide (2007-10-23),
8. 7273695 - HIV immunoassays using synthetic envelope polypeptides (2007-09-25),
9. 7205101 - Human immunodeficiency virus (HIV) nucleotide sequences, recombinant polypeptides, and applications thereof (2007-04-17),
10. 6531276 - Methods for detecting human immunodeficiency virus nucleic acid (2003-03-11),
11. 6458527 - HIV immunoassays using gag polypeptides (2002-10-01),
12. 6326007 - Attenuated lentivirus vectors expressing interferon (2001-12-04),
13. 6013432 - Immunoassay of HIV antibodies using recombinant or synthetic selected (2000-01-11),
14. 6004799 - Recombinant live feline immunodeficiency virus and proviral DNA vaccines (1999-12-21),
15. 5688688 - Vector for expression of a polypeptide in a mammalian cell (1997-11-18),

Title: The Innovative Journey of Paul A Luciw

Introduction: Paul A Luciw, a pioneering inventor hailing from Davis, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Paul A Luciw's latest patents include cutting-edge advancements in artificial intelligence, renewable energy technologies, and medical devices, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Paul A Luciw has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has not only revolutionized industries but has also improved the quality of life for many individuals around the world.

Collaborations: Throughout his career, Paul A Luciw has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: In conclusion, Paul A Luciw's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, has solidified his reputation as a trailblazing inventor. His relentless pursuit of excellence continues to inspire the next generation of inventors to think big and create a better future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…